Livdelzi Capsule
Product Images NDC 61958-3301

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Livdelzi (NDC 61958-3301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Seladelpar 01)

Chemical structure depicting the active ingredient Seladelpar Lysine, shown as a molecular formula with associated lysine and water molecules.*

FDA Label Image

Figure 1 (Seladelpar 02)

Line graph comparing ALP (U/L) levels over 12 months between Livdelzi 10 mg capsules (N=128) and placebo (N=65). The graph shows a significant decrease in ALP levels with Livdelzi over time, while levels remain relatively stable with placebo. Error bars indicate variability at each time point.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Livdelzi 10 mg oral capsules label showing active ingredient seladelpar. The label indicates a package containing 30 capsules for oral use only, distributed by Gilead Sciences, Inc. It includes storage instructions and prescription usage details along with the proprietary name in green font.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.